Financial intelligence for Asia's healthcare markets
Remember me:

Opinion: Europe remains a problem for Ramsay

Yesterday’s stock price fall for Ramsay Health Care was not entirely unexpected. Shares in Australia’s largest private hospital operator dropped 5.75% to A$63.90 (US$49.81) after it revealed distinctly unimpressive first half figures.

Profits were down 3.7% to A$246.5 million.

Managing director Craig McNally admitted “ongoing challenges in the operating environment in Europe”. He wasn’t wrong and nor is the outlook expected to get better any time soon.

At the heart of the problem is Ramsay Générale de Santé, its French business, acquired in October 2014. Revenues fell 1.1% to €1.1 billion (US$1.35 billion) and EBITDAR was down 5.8% to €194.1 million.

“We are focused on achieving efficiencies in these businesses and, to this end, we are investing in a major transformation project in our French operations that will centralise non-core hospital resources and distinguish this business for the long term,” he said. Non-core hospital functions such as finance, administration and HR, will be relocated to a separate shared service centre in the outer suburbs of Paris

All good news, but this is not going to start until the second half and is going to take three years. A sign of how disruptive this is going to be is that Ramsay has provided for a restructuring charge of €43.7 million.

Although its presence is smaller, business is not much better in the UK. British revenues fell 4.8% to £206.2 million (US$286.7 million) with EBITDAR down 4.6% to £49.4 million thanks to NHS management demand strategies.

The issue for investors is that there are no discernable upsides in the short term. Pollyannas could point to Australian revenues. Domestic turnover was indeed up 4.3% to A$2.5 billion with a pleasing 9.1% jump in corresponding EBIT, but proposed caps on health insurance premia from the opposition Labor party could soon bring that growth to a shuddering halt.

Demographic trends and an aging population still support the Ramsay business case, but the next couple of years are going to be anything other than easy.

Posted on: 01/03/2018 UTC+08:00


China Isotope & Radiation, which manufactures diagnostic and therapeutic radiopharmaceuticals products, has launched its HK$1.9 billion (US$247 million) IPO on the Hong Kong Stock Exchange.
Malaysian multinational PRG Holdings has extended the deadline for its M$18.3 million (US$4.6 million) acquisition of O&G focused private medical services provider Roopi Medical Centre.
Hong Kong-listed WuXi Biologics, a subsidiary of WuXi PharmaTech, has started the construction of an integrated biologics conjugate solution centre in Wuxi city.
RHT Health Trust, the first business trust listed on the Singapore stock exchange with a portfolio comprising healthcare assets in India, has confirmed that it has received all outstanding amounts due from India’s Fortis Healthcare for the past financial year.
Shares in Ramsay Health Care, Australia’s largest private hospital operator, slumped today after the group cut earnings guidance. It flagged up “onerous lease provisions” and asset writedowns on a number of its hospitals in the UK.
Following Monday’s 5.9 magnitude earthquake which struck Osaka, Parkway Life REIT, which is owned by IHH Healthcare, has confirmed that its Japan asset managers, operators and residents at its Japan healthcare facilities are accounted for with no reported injuries.
Singapore-listed property developer Perennial Real Estate has incorporated a new subsidiary in China. Perennial (Shanghai) Health Management will be involved in the management of its healthcare business in Shanghai.
Yestar Aesthetic Medical Group, the second largest private aesthetic medical institution group in China, is planning an IPO on Hong Kong’s mainboard. CICC is sole sponsor to the deal.


Aon’s inaugural Asia Healthcare Trends Report 2017/18 shows that although Hong Kong has a lower medical inflation rate than the average in APAC, it is the highest in Greater China.
Out of date and unsecure fax machines are still being used to share patient information between healthcare providers in Australia. Not only do fax machines cause frustration for healthcare providers trying to communicate with each other, they can also cause patient harm.
Health and well-being programmes are fragmented and do not meet the needs of stressed Asia workforces, finds Willis Towers Watson. By and large, employers in Asia still miss the mark when it comes to their health and well-being benefits, with many employees feeling that their needs are not met, according to research from the global advisory, broking and solutions company.
According to a survey of biopharma companies by L.E.K. Consulting, the majority of firms from Western Europe or the US are interested in China, specifically those at Phase 2 or later development.
Sara Jost, global healthcare industry lead at BlackBerry, explains that putting the systems and procedures in place to deliver a healthy and secure digital healthcare system will protect patient health information and support medical innovation.
Joseph Soon, global digital director at Bupa, explains why industry players must stay agile in the market and act fast to take every opportunity the digital age has to offer.
The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.
Tan Chorh Chuan, executive director at the Office for Healthcare Transformation and chief health scientist at the Ministry of Health in Singapore, explains why population health improvement has to become a crucial area of focus.
my images


HealthInvestor Asia twitter feed